Premium Peptide

BURNETRA®

(Retatrutide)

Metabolic Health & Weight Management

Burnetra is an advanced peptide formulation featuring Retatrutide — a triple receptor agonist designed to support appetite regulation, metabolic optimization, and sustainable weight management under pharmaceutical-grade standards.

  • Triple Receptor Agonist
  • Clinical Grade Peptide
  • Cold Chain Shipping
  • ISO Certified
Burnetra

$1.00

In Stock

Quantity
  • Secure Payment
  • Fast & Discreet Shipping
  • Cold-chain shipped
  • Authentic Product

Why Burnetra?

Appetite Regulation

Supports appetite control and promotes satiety.

Metabolic Efficiency

Helps improve metabolic activity and energy utilization.

Healthy Weight Management

Supports sustainable weight management alongside lifestyle changes.

Body Composition Support

Complements lean body composition goals.

How Burnetra Works

  1. 01
    GLP-1 ActivationIntestines & stomach
  2. 02
    GIP ActivationPancreas
  3. 03
    Glucagon RegulationLiver

  4. Metabolic Optimization

    • Sustained Weight Loss
    • Improved Glucose Control
    • Enhanced Energy Expenditure
    • Body Composition Support

Available Strengths

Select your preferred strength below.

Burnetra

20mg per vial

Product Specifications

Product Name Burnetra® (Retatrutide)
Active Ingredient Retatrutide
Classification Research Peptide
Target Pathways GLP-1, GIP, Glucagon
Purity ≥ 99% (HPLC verified)
Appearance Lyophilized white powder
Storage 2°C – 8°C
Shelf Life 24 months (unopened)
Packing Unit 1 Vial
Cold Chain Validated 2°C – 8°C
Reconstitution Bacteriostatic water
Administration Healthcare Professional

Triple Receptor Agonist Technology

Once Weekly Administration

Cold Chain Storage

For Healthcare Professionals Only

Mechanism of Action

GLP-1

Function: Appetite and gastric emptying regulation

Pathway: Incretin signaling cascade

Outcome: Reduced caloric intake

GIP

Function: Insulin secretion and lipid metabolism

Pathway: GIP receptor activation

Outcome: Improved glucose control

Glucagon

Function: Energy expenditure enhancement

Pathway: Glucagon receptor modulation

Outcome: Increased metabolic rate

Clinical Outcomes

  • Weight Loss
  • Metabolic Health
  • Insulin Sensitivity
  • Body Composition

Safety & Clinical Information

Everything healthcare professionals need to know

Safety Information

  • Contraindications

    Not for use in patients with personal or family history of medullary thyroid carcinoma or MEN 2.

  • Pregnancy

    Contraindicated during pregnancy and breastfeeding. Discontinue if pregnancy is detected.

  • Drug Interactions

    May affect absorption of oral medications. Consult prescribing physician for interaction review.

  • Common Side Effects

    Nausea, decreased appetite, and gastrointestinal discomfort — typically mild and transient during titration.

  • When To Seek Medical Advice

    Persistent vomiting, severe abdominal pain, or signs of allergic reaction require immediate medical attention.

  • Emergency Symptoms

    Difficulty breathing, swelling of face or throat, or severe hypersensitivity — seek emergency care immediately.

Important Information

  • Educational Use Only

    For educational and research purposes under qualified supervision.

  • Investigational Compound

    Retatrutide is an investigational peptide. Regulatory status varies by jurisdiction.

  • Consult Healthcare Professional

    Always consult a licensed healthcare provider before use.

  • Research Purposes

    Intended for research and clinical protocols — not for self-administration.

  • Not Medical Advice

    Content on this page does not constitute medical advice or treatment recommendation.

  • Clinical Disclaimer

    Individual results may vary. Follow institutional protocols and local regulations.

FAQ

Burnetra is typically administered once weekly under healthcare professional supervision, following a structured escalation protocol.

Store between 2°C and 8°C, protected from light. Do not freeze. Maintain cold chain throughout distribution.

Burnetra is intended for administration by qualified healthcare professionals following validated clinical protocols.

Duration depends on prescribed dose and frequency. Consult your healthcare provider for supply planning based on your protocol.

Burnetra is available in 20mg, 30mg, 40mg, 50mg, and 60mg strengths to support flexible dosing protocols.

Related Peptides